NCT03515382View on ClinicalTrials.gov

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Healthy
Interventions
DRUG

GLPG1690

A single oral dose of GLPG1690.

DRUG

Itraconazole

A single oral dose of itraconazole.

DRUG

Voriconazole

A single oral dose of voriconazole.

Trial Locations (1)

Unknown

Quotient Sciences Limited, Ruddington

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY